In tumor cells, accompanied by the activation of the IL-6/STAT3 signaling pathway, phosphorylated STAT3 can bind to the promoter of the p53 gene to inhibit its transcription, thereby blocking the inhibitory effect of p53 on oncogene transcription (61). Here, TP53 is linked to neoplasm.